{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:50:52Z","timestamp":1793854252594,"version":"4.6.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG044546"],"award-info":[{"award-number":["R01AG044546"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG003991"],"award-info":[{"award-number":["P01AG003991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG053303"],"award-info":[{"award-number":["RF1AG053303"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG058501"],"award-info":[{"award-number":["RF1AG058501"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AG058922"],"award-info":[{"award-number":["U01AG058922"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AG066444"],"award-info":[{"award-number":["P30AG066444"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG03991"],"award-info":[{"award-number":["P01AG03991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG026276"],"award-info":[{"award-number":["P01AG026276"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human proteins are widely used as drug targets. Integration of large-scale protein-level genome-wide association studies (GWAS) and disease-related GWAS has thus connected genetic variation to disease mechanisms via protein. Previous proteome-by-phenome-wide Mendelian randomization (MR) studies have been mainly focused on plasma proteomes. Previous MR studies using the brain proteome only reported protein effects on a set of pre-selected tissue-specific diseases. No studies, however, have used high-throughput proteomics from multiple tissues to perform MR on hundreds of phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here, we performed MR and colocalization analysis using multi-tissue (cerebrospinal fluid (CSF), plasma, and brain from pre- and post-meta-analysis of several disease-focus cohorts including Alzheimer disease (AD)) protein quantitative trait loci (pQTLs) as instrumental variables to infer protein effects on 211 phenotypes, covering seven broad categories: biological traits, blood traits, cancer types, neurological diseases, other diseases, personality traits, and other risk factors. We first implemented these analyses with cis pQTLs, as cis pQTLs are known for being less prone to horizontal pleiotropy. Next, we included both cis and trans conditionally independent pQTLs that passed the genome-wide significance threshold keeping only variants associated with fewer than five proteins to minimize pleiotropic effects. We compared the tissue-specific protein effects on phenotypes across different categories. Finally, we integrated the MR-prioritized proteins with the druggable genome to identify new potential targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the MR and colocalization analysis including study-wide significant cis pQTLs as instrumental variables, we identified 33 CSF, 13 plasma, and five brain proteins to be putative causal for 37, 18, and eight phenotypes, respectively. After expanding the instrumental variables by including genome-wide significant cis and trans pQTLs, we identified a total of 58 CSF, 32 plasma, and nine brain proteins associated with 58, 44, and 16 phenotypes, respectively. For those protein-phenotype associations that were found in more than one tissue, the directions of the associations for 13 (87%) pairs were consistent across tissues. As we were unable to use methods correcting for horizontal pleiotropy given most of the proteins were only associated with one valid instrumental variable after clumping, we found that the observations of protein-phenotype associations were consistent with a causal role or horizontal pleiotropy. Between 66.7 and 86.3% of the disease-causing proteins overlapped with the druggable genome. Finally, between one and three proteins, depending on the tissue, were connected with at least one drug compound for one phenotype from both DrugBank and ChEMBL databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Integrating multi-tissue pQTLs with MR and the druggable genome may open doors to pinpoint novel interventions for complex traits with no effective treatments, such as ovarian and lung cancers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13073-022-01140-9","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T10:03:19Z","timestamp":1670839399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes"],"prefix":"10.1186","volume":"14","author":[{"given":"Chengran","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herve","family":"Rhinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0276-2899","authenticated-orcid":false,"given":"Carlos","family":"Cruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"1140_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess S, Davey Smith G, Davies NM, Dudbridge F, Gill D, Glymour MM, et al. Guidelines for performing Mendelian randomization investigations. Wellcome Open Res. 2019;4:186.","journal-title":"Wellcome Open Res"},{"key":"1140_CR2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Loos R, editor. eLife. 2018;7:e34408.","journal-title":"eLife"},{"key":"1140_CR3","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10:e1004383 Public Library of Science.","journal-title":"PLoS Genet"},{"key":"1140_CR4","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41467-020-20885-8","volume":"12","author":"CN Foley","year":"2021","unstructured":"Foley CN, Staley JR, Breen PG, Sun BB, Kirk PDW, Burgess S, et al. A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits. Nat Commun. 2021;12:764 Nature Publishing Group.","journal-title":"Nat Commun"},{"key":"1140_CR5","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.ajhg.2016.10.003","volume":"99","author":"F Hormozdiari","year":"2016","unstructured":"Hormozdiari F, van de Bunt M, Segr\u00e8 AV, Li X, Joo JWJ, Bilow M, et al. Colocalization of GWAS and eQTL signals detects target genes. Am J Hum Genet. 2016;99:1245\u201360.","journal-title":"Am J Hum Genet"},{"key":"1140_CR6","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ajhg.2020.04.007","volume":"106","author":"NK Kibinge","year":"2020","unstructured":"Kibinge NK, Relton CL, Gaunt TR, Richardson TG. Characterizing the causal pathway for genetic variants associated with neurological phenotypes using human brain-derived proteome data. Am J Hum Genet. 2020;106:885\u201392.","journal-title":"Am J Hum Genet"},{"key":"1140_CR7","doi-asserted-by":"crossref","unstructured":"Zheng J, Haberland V, Baird D, Walker V, Haycock PC, Hurle MR, et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet. 2020;52:1122\u201331. Nature Publishing Group.","DOI":"10.1038\/s41588-020-0682-6"},{"key":"1140_CR8","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","volume":"11","author":"AF Schmidt","year":"2020","unstructured":"Schmidt AF, Finan C, Gordillo-Mara\u00f1\u00f3n M, Asselbergs FW, Freitag DF, Patel RS, et al. Genetic drug target validation using Mendelian randomisation. Nat Commun. 2020;11:3255 Nature Publishing Group.","journal-title":"Nat Commun"},{"key":"1140_CR9","doi-asserted-by":"crossref","unstructured":"Holmes MV, Richardson TG, Ference BA, Davies NM, Davey SG. Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development. Nat Rev Cardiol. 2021;18:435\u201353. Nature Publishing Group.","DOI":"10.1038\/s41569-020-00493-1"},{"key":"1140_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cels.2020.10.005","volume":"12","author":"J Molendijk","year":"2021","unstructured":"Molendijk J, Parker BL. Proteome-wide systems genetics to identify functional regulators of complex traits. Cell Syst. 2021;12:5\u201322.","journal-title":"Cell Syst"},{"key":"1140_CR11","doi-asserted-by":"publisher","first-page":"eaau2291","DOI":"10.1126\/scitranslmed.aau2291","volume":"11","author":"Y Deming","year":"2019","unstructured":"Deming Y, Filipello F, Cignarella F, Cantoni C, Hsu S, Mikesell R, et al. The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer\u2019s disease risk. Sci Transl Med. 2019;11:eaau2291.","journal-title":"Sci Transl Med"},{"key":"1140_CR12","doi-asserted-by":"crossref","unstructured":"Gill D, Arvanitis M, Carter P, Cordero AIH, Jo B, Karhunen V, et al. ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study.\u00a0R Soc Open Sci. 2020;7:200958. Cold Spring Harbor Laboratory Press.","DOI":"10.1098\/rsos.200958"},{"key":"1140_CR13","doi-asserted-by":"crossref","unstructured":"Zhou S, Butler-Laporte G, Nakanishi T, Morrison DR, Afilalo J, Afilalo M, et al. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity. Nat Med. 2021;27:659\u201367. Nature Publishing Group.","DOI":"10.1038\/s41591-021-01281-1"},{"key":"1140_CR14","doi-asserted-by":"publisher","first-page":"e1008785","DOI":"10.1371\/journal.pgen.1008785","volume":"16","author":"AD Bretherick","year":"2020","unstructured":"Bretherick AD, Canela-Xandri O, Joshi PK, Clark DW, Rawlik K, Boutin TS, et al. Linking protein to phenotype with Mendelian randomization detects 38 proteins with causal roles in human diseases and traits. PLoS Genet. 2020;16:e1008785 Public Library of Science.","journal-title":"PLoS Genet"},{"key":"1140_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41576-021-00387-z","volume":"22","author":"WR Reay","year":"2021","unstructured":"Reay WR, Cairns MJ. Advancing the use of genome-wide association studies for drug repurposing. Nat Rev Genet. 2021;22:658\u201371.","journal-title":"Nat Rev Genet."},{"key":"1140_CR16","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","volume":"24","author":"C Yang","year":"2021","unstructured":"Yang C, Farias FHG, Ibanez L, Suhy A, Sadler B, Fernandez MV, et al. Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat Neurosci. 2021;24:1302\u201312.","journal-title":"Nat Neurosci."},{"key":"1140_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold L, Ayers D, Bertino J, Bock C, Bock A, Brody EN, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One. 2010;5:e15004.","journal-title":"PLoS One"},{"key":"1140_CR18","doi-asserted-by":"publisher","unstructured":"Dong X, Li X, Chang T-W, Scherzer CR, Weiss ST, Qiu W. powerEQTL: an R package and shiny application for sample size and power calculation of bulk tissue and single-cell eQTL analysis. Bioinformatics. 2021. https:\/\/doi.org\/10.1093\/bioinformatics\/btab385 [cited 2021 Jun 18].","DOI":"10.1093\/bioinformatics\/btab385"},{"key":"1140_CR19","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","volume":"26","author":"CJ Willer","year":"2010","unstructured":"Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190\u20131.","journal-title":"Bioinformatics."},{"key":"1140_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"K Marek","year":"2011","unstructured":"Marek K, Jennings D, Lasch S, Siderowf A, Tanner C, Simuni T, et al. The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol. 2011;95:629\u201335.","journal-title":"Prog Neurobiol"},{"key":"1140_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558:73\u20139.","journal-title":"Nature."},{"key":"1140_CR22","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s42255-020-00287-2","volume":"2","author":"L Folkersen","year":"2020","unstructured":"Folkersen L, Gustafsson S, Wang Q, Hansen DH, Hedman \u00c5K, Schork A, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat Metab. 2020;2:1135\u201348 Nature Publishing Group.","journal-title":"Nat Metab"},{"key":"1140_CR23","doi-asserted-by":"publisher","unstructured":"Elsworth BL, Lyon MS, Alexander T, Liu Y, Matthews P, Hallett J, et al. The MRC IEU OpenGWAS data infrastructure. bioRxiv. 2020; 2020.08.10.244293.\u00a0https:\/\/doi.org\/10.1101\/2020.08.10.244293. Cold Spring Harbor Laboratory.","DOI":"10.1101\/2020.08.10.244293"},{"key":"1140_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13059-020-02248-0","volume":"22","author":"MS Lyon","year":"2021","unstructured":"Lyon MS, Andrews SJ, Elsworth B, Gaunt TR, Hemani G, Marcora E. The variant call format provides efficient and robust storage of GWAS summary statistics. Genome Biol. 2021;22:32.","journal-title":"Genome Biol"},{"key":"1140_CR25","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.3406","volume":"47","author":"B Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh P-R, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47:1236\u201341.","journal-title":"Nat Genet"},{"key":"1140_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-98141-3","volume-title":"ggplot2: elegant graphics for data analysis [Internet]","author":"H Wickham","year":"2009","unstructured":"Wickham H. ggplot2: elegant graphics for data analysis [Internet]. New York: Springer-Verlag; 2009. [cited 2020 Mar 3]. Available from: https:\/\/www.springer.com\/gp\/book\/9780387981413"},{"key":"1140_CR27","doi-asserted-by":"publisher","first-page":"e1009440","DOI":"10.1371\/journal.pgen.1009440","volume":"17","author":"C Wallace","year":"2021","unstructured":"Wallace C. A more accurate method for colocalisation analysis allowing for multiple causal variants. PLoS Genet. 2021;17:e1009440 Public Library of Science.","journal-title":"PLoS Genet"},{"key":"1140_CR28","doi-asserted-by":"crossref","unstructured":"Wang G, Sarkar A, Carbonetto P, Stephens M. A simple new approach to variable selection in regression, with application to genetic fine mapping. J R Stat Soc Series B Stat Methodology. 2020;n\/a [cited 2020 Jul 22]. Available from: https:\/\/rss.onlinelibrary.wiley.com\/doi\/abs\/10.1111\/rssb.12388.","DOI":"10.1111\/rssb.12388"},{"key":"1140_CR29","doi-asserted-by":"publisher","unstructured":"Liu Y, Elsworth B, Erola P, Haberland V, Hemani G, Lyon M, et al. EpiGraphDB: a database and data mining platform for health data science. Bioinformatics. 2020. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa961 [cited 2021 Mar 10].","DOI":"10.1093\/bioinformatics\/btaa961"},{"key":"1140_CR30","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1073\/pnas.1530509100","volume":"100","author":"JD Storey","year":"2003","unstructured":"Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100:9440\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1140_CR31","doi-asserted-by":"crossref","unstructured":"Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J, et al. The druggable genome and support for target identification and validation in drug development. Sci Transl Med. 2017;9 [cited 2021 Jan 15]. Available from: https:\/\/stm.sciencemag.org\/content\/9\/383\/eaag1166. American Association for the Advancement of Science.","DOI":"10.1126\/scitranslmed.aag1166"},{"key":"1140_CR32","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","volume":"47","author":"D Mendez","year":"2019","unstructured":"Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, F\u00e9lix E, et al. ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res. 2019;47:D930\u201340.","journal-title":"Nucleic Acids Res"},{"key":"1140_CR33","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34:D668\u201372.","journal-title":"Nucleic Acids Res"},{"key":"1140_CR34","doi-asserted-by":"publisher","first-page":"D506","DOI":"10.1093\/nar\/gky1049","volume":"47","author":"UniProt Consortium","year":"2019","unstructured":"UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47:D506\u201315 Oxford Academic.","journal-title":"Nucleic Acids Res"},{"key":"1140_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/567351","volume":"2010","author":"J-H Lee","year":"2010","unstructured":"Lee J-H, Wang L-C, Yu H-H, Lin Y-T, Yang Y-H, Chiang B-L. Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma. Mediators Inflamm. 2010;2010:567351.","journal-title":"Mediators Inflamm"},{"key":"1140_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/ng.3510","volume":"48","author":"LM Boettger","year":"2016","unstructured":"Boettger LM, Salem RM, Handsaker RE, Peloso GM, Kathiresan S, Hirschhorn JN, et al. Recurring exon deletions in the HP (haptoglobin) gene contribute to lower blood cholesterol levels. Nat Genet. 2016;48:359\u201366.","journal-title":"Nat Genet"},{"key":"1140_CR37","doi-asserted-by":"publisher","first-page":"4089459","DOI":"10.1155\/2018\/4089459","volume":"2018","author":"R O\u2019Dwyer","year":"2018","unstructured":"O\u2019Dwyer R, Kovaleva M, Zhang J, Steven J, Cummins E, Luxenberg D, et al. Anti-ICOSL new antigen receptor domains inhibit T cell proliferation and reduce the development of inflammation in the collagen-induced mouse model of rheumatoid arthritis. J Immunol Res. 2018;2018:4089459.","journal-title":"J Immunol Res"},{"key":"1140_CR38","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1093\/brain\/awab337","volume":"144","author":"N Magusali","year":"2021","unstructured":"Magusali N, Graham AC, Piers TM, Panichnantakul P, Yaman U, Shoai M, et al. A genetic link between risk for Alzheimer\u2019s disease and severe COVID-19 outcomes via the OAS1 gene. Brain. 2021;144:3727\u201341.","journal-title":"Brain."},{"key":"1140_CR39","doi-asserted-by":"crossref","unstructured":"Ochoa D, Karim M, Ghoussaini M, Hulcoop DG, McDonagh EM, Dunham I. Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs. Nat Rev Drug Discov. 2022; [cited 2022 Jul 8]; Available from: https:\/\/www.nature.com\/articles\/d41573-022-00120-3.","DOI":"10.1038\/d41573-022-00120-3"},{"key":"1140_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002431","volume":"8","author":"J Fu","year":"2012","unstructured":"Fu J, Wolfs MGM, Deelen P, Westra H-J, Fehrmann RSN, Te Meerman GJ, et al. Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLoS Genet. 2012;8:e1002431.","journal-title":"PLoS Genet"},{"key":"1140_CR41","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/s41431-019-0468-4","volume":"27","author":"A Mizuno","year":"2019","unstructured":"Mizuno A, Okada Y. Biological characterization of expression quantitative trait loci (eQTLs) showing tissue-specific opposite directional effects. Eur J Hum Genet. 2019;27:1745\u201356.","journal-title":"Eur J Hum Genet."},{"key":"1140_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41467-019-13921-9","volume":"11","author":"TG Richardson","year":"2020","unstructured":"Richardson TG, Hemani G, Gaunt TR, Relton CL, Davey SG. A transcriptome-wide Mendelian randomization study to uncover tissue-dependent regulatory mechanisms across the human phenome. Nat Commun. 2020;11:185.","journal-title":"Nat Commun"},{"key":"1140_CR43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/gastro\/gox034","volume":"7","author":"R Nemati","year":"2019","unstructured":"Nemati R, Mehdizadeh S, Salimipour H, Yaghoubi E, Alipour Z, Tabib SM, et al. Neurological manifestations related to Crohn\u2019s disease: a boon for the workforce. Gastroenterol Rep. 2019;7:291\u20137.","journal-title":"Gastroenterol Rep"},{"key":"1140_CR44","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1212\/WNL.45.3.416","volume":"45","author":"A Lossos","year":"1995","unstructured":"Lossos A, River Y, Eliakim A, Steiner I. Neurologic aspects of inflammatory bowel disease. Neurology. 1995;45:416\u201321 Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.","journal-title":"Neurology"},{"key":"1140_CR45","first-page":"8764","volume":"20","author":"G Casella","year":"2014","unstructured":"Casella G, Tontini GE, Bassotti G, Pastorelli L, Villanacci V, Spina L, et al. Neurological disorders and inflammatory bowel diseases. World J Gastroenterol. 2014;20:8764\u201382.","journal-title":"World J Gastroenterol"},{"key":"1140_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Sig Transduct Target Ther. 2020;5:1\u201317 Nature Publishing Group.","journal-title":"Sig Transduct Target Ther"},{"key":"1140_CR47","doi-asserted-by":"crossref","unstructured":"Wong A, Ye M, Levy A, Rothstein J, Bergles D, Searson P. The blood-brain barrier: an engineering perspective. Front Neuroeng. 2013;6 [cited 2022 Jul 29]. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fneng.2013.00007.","DOI":"10.3389\/fneng.2013.00007"},{"key":"1140_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11126-011-9186-y","volume":"83","author":"JR Jackson","year":"2012","unstructured":"Jackson JR, Eaton WW, Cascella NG, Fasano A, Kelly DL. Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. Psychiatry Q. 2012;83:91\u2013102.","journal-title":"Psychiatry Q"},{"key":"1140_CR49","doi-asserted-by":"publisher","first-page":"e010710","DOI":"10.1161\/CIRCIMAGING.120.010710","volume":"13","author":"K Moazzami","year":"2020","unstructured":"Moazzami K, Wittbrodt MT, Alkhalaf M, Lima BB, Nye JA, Mehta PK, et al. Association between mental stress-induced inferior frontal cortex activation and angina in coronary artery disease. Circ Cardiovasc Imaging. 2020;13:e010710 American Heart Association.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1140_CR50","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"The GTEx Consortium","year":"2020","unstructured":"The GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318\u201330 American Association for the Advancement of Science.","journal-title":"Science."},{"key":"1140_CR51","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41588-018-0154-4","volume":"50","author":"ER Gamazon","year":"2018","unstructured":"Gamazon ER, Segr\u00e8 AV, van de Bunt M, Wen X, Xi HS, Hormozdiari F, et al. Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation. Nat Genet. 2018;50:956\u201367 Nature Publishing Group.","journal-title":"Nat Genet"},{"key":"1140_CR52","first-page":"124","volume":"32","author":"A Mertz","year":"2019","unstructured":"Mertz A, Nguyen NA, Katsanos KH, Kwok RM. Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence. Ann Gastroenterol. 2019;32:124\u201333.","journal-title":"Ann Gastroenterol"},{"key":"1140_CR53","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512\u201325.","journal-title":"Int J Epidemiol"},{"key":"1140_CR54","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u20138 Nature Publishing Group.","journal-title":"Nat Genet"},{"key":"1140_CR55","doi-asserted-by":"publisher","first-page":"e1009224","DOI":"10.1371\/journal.pgen.1009224","volume":"17","author":"DA Baird","year":"2021","unstructured":"Baird DA, Liu JZ, Zheng J, Sieberts SK, Perumal T, Elsworth B, et al. Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome. PLOS Genet. 2021;17:e1009224 Public Library of Science.","journal-title":"PLOS Genet"},{"key":"1140_CR56","volume-title":"Multi-tissue pQTL from Knight ADRC cohort: CSF. GWAS-Catalog","author":"C Yang","year":"2022","unstructured":"Yang C, Cruchaga C. Multi-tissue pQTL from Knight ADRC cohort: CSF. GWAS-Catalog. 2022; GCST90204140"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-022-01140-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-022-01140-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-022-01140-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T11:06:20Z","timestamp":1670843180000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-022-01140-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1140"],"URL":"https:\/\/doi.org\/10.1186\/s13073-022-01140-9","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"10 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided informed written consent to participate in the study. This research was approved by the ethical committee of the Washington University School of Medicine in St. Louis. The reference number of the Institutional Review Board approval is 201109148. This research conformed to the principles of the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CC receives research support from GSK. CC is a member of the advisory board of Vivid Genomics and Circular Genomics. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}